Skip to main content

Racial Bias in Pulse Oximetry Measures May Impact Treatment for Black Patients

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 28, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Feb. 28, 2024 -- In Black patients, Fick cardiac output (CO) may be underestimated using peripheral oxygen saturation (SpO2) versus arterial oxygen saturation (SaO2), according to a research letter published online Feb. 6 in Circulation: Cardiovascular Quality and Outcomes.

Scott W. Ketcham, M.D., from the University of Michigan in Ann Arbor, and colleagues identified 204 adult patients admitted to a single institution’s medical or surgical cardiac intensive care units between Jan. 1, 2016, and Aug. 31, 2022, with a pulmonary artery catheter and recorded the first simultaneous (within one hour) SpO2 and SaO2, hemoglobin, and invasive hemodynamics after pulmonary artery catheter placement.

The researchers found that median SpO2 was higher than SaO2 in Black patients (99.0 versus 93.0 percent) compared with White patients (98.0 versus 97.0 percent). CO calculations were equal to 1 decimal point in 88.1 percent of White patients, while measurements were equal in only 2.2 percent of Black patients. For Fick calculations, the average absolute difference in CO between SaO2 and SpO2 was 0.93 in Black patients versus 0.05 in White patients. The average absolute difference in CO among patients with low CO was higher in Black versus White patients (0.46 versus 0.02). For Black versus White patients, the average difference in CO was significantly lower when using SpO2 versus SaO2.

"While Fick CO is only one variable that must be interpreted in the context of a patient’s entire clinical picture, an erroneous value can overestimate the severity of acute decompensated heart failure and possibly influence decisions related to the use of inotropes, afterload-reducing agents, and mechanical circulatory support," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.